CVRdatabase
Menu

Glaxosmithkline Pharma A/S

Public limited companyCVR 27394019Vallensbæk StrandActive

Glaxosmithkline Pharma A/S is a public limited company, based in Vallensbæk Strand, active in wholesale of pharmaceutical goods and nursing supplies, founded in 1968. Net profit rose 7% from 2024 to 2025, ending at DKK 13.1m. Profit has grown three years in a row. With 82 employees, the company is about 9 times larger than the industry median.

Follow
PDF reportCompare

Key figures · financial year 2025

RevenueDKK 580.8m+5.9% vs. 2024
Net profitDKK 13.1m+7.2% vs. 2024
EquityDKK 39m+2.3% vs. 2024
Employees82latest month from CVR

What has changed

calculated from recorded figures and dates

Financials: 2025 against 2024

  • Gross profit fell 12% (2024 → 2025), to DKK 118.8m.
  • Revenue rose 6% (2024 → 2025), to DKK 580.8m.
  • Net profit rose 7% (2024 → 2025), to DKK 13.1m.
  • Equity rose 2% (2024 → 2025), to DKK 39m.

Management and owners, last 24 months

  • New in management: Luciano Alves de Andrade (chair of the board, 18/06/2025), Diederik Maarten Eijsvogel (board member, 26/08/2025) and Diederik Maarten Eijsvogel (director, 26/08/2025) (+2).
  • Stepped down: Patrick Gerard Connor (chair of the board, 18/06/2025), Hemal Depan Malde (board member, 15/01/2025) and Dominika M Wiktor-Brown (board member, 26/08/2025) (+2).

Registrations, last 24 months

  • 03/04/2025: Moved to Delta Park 37, 2665 Vallensbæk Strand
  • 03/01/2025: Moved to Delta Park 37, 2665 Vallensbæk Strand

Calculated from the latest two annual reports in sequence and from registrations in CVR. A figure that is missing in either year gives no line, and we derive no figures.

Financial statements

Financial years 2020–2025 · amounts in DKK thousand

Equity and net profit

DKK 0DKK 5mDKK 10mDKK 15mDKK 20mDKK 25mDKK 30mDKK 35mDKK 40m202020212022202320242025
EquityNet profit
Financial figures for Glaxosmithkline Pharma A/S
202020212022202320242025Change
Revenue441,702445,873440,283474,477548,470580,769+5.9%
Gross profit120,336111,627126,161119,781134,534118,765−11.7%
Operating profit (EBIT)14,630−11,00114,000––17,430–
Profit before tax14,55114,30914,34115,46316,26517,621+8.3%
Net profit12,2718,98411,06812,00312,24013,123+7.2%
Total assets160,064137,489115,803117,32499,094120,705+21.8%
Equity37,79434,77836,94637,88938,12939,017+2.3%
Liabilities121,292102,02678,64779,43560,96581,688+34%
Average number of employees626668727371,000+97,160.3%

Source: annual reports filed with the Danish Business Authority (XBRL). Figures for the company (not the group); change is the latest year against the year before. “–” means the figure is not stated in the annual report.

Download the figures as CSV · free with an account, amounts in whole DKK

DKK 0DKK 20mDKK 40mDKK 60mDKK 80mDKK 100mDKK 120mDKK 140m202020212022202320242025
Gross profitMedian, the industry (232 companies)

Signals from the financial statements

calculated from the 2025 figures

  • Profit for five years in a row

    Net result has been positive in 2021–2025.

    How is this calculated?

    Net result is positive in the five latest annual reports in a row.

The signals are rules applied to the figures in the annual reports. They are not an assessment or credit rating of the company. See Data and method.

Annual reports

6 financial years
Annual reports for Glaxosmithkline Pharma A/S
Financial yearPeriodPublishedFigures forDocuments
202501/01/2025 – 31/12/202525/06/2026The companyPDF not statedXBRL
202401/01/2024 – 31/12/202426/06/2025The companyPDF not statedXBRL
202301/01/2023 – 31/12/202326/06/2024The companyPDFXBRL
202201/01/2022 – 31/12/202221/06/2023The companyPDFXBRL
202101/01/2021 – 31/12/202128/06/2022The companyPDFXBRL
202001/01/2020 – 31/12/202031/05/2021The companyPDFXBRL

The figures from all the annual reports are shown on this page. The documents themselves (PDF and XBRL, the machine-readable edition) are downloaded with a Pro account: sign in or create a free account, and then choose Pro. XBRL is the edition the figures on the page are read from.

Employees

monthly figures from CVR
02040608009/2310/2311/2312/2301/2402/2403/2404/2405/2406/2407/2408/2409/2410/2411/2412/2401/2502/2503/2504/2505/2506/2507/2508/2509/2510/2511/2512/2501/2602/2603/2604/2605/2606/2607/2608/26
Employees

Position in the industry

232 companies in the database

Comparison with the other companies in wholesale of pharmaceutical goods and nursing supplies based on the latest financial year.

Gross profitDKK 118.8mNo. 24 of 232
Better than 90% of the companies in the industry
EquityDKK 39mNo. 63 of 232
Better than 73% of the companies in the industry
Number of employees82No. 4 of 232
Better than 99% of the companies in the industry

Industry median: gross profit DKK 11.2m, net profit DKK 1.8m, equity DKK 9.6m, 9 employees.

DKK 100kDKK 1.4mDKK 19.1mDKK 263.2mDKK 1.5bnHere
Distribution of gross profit for 225 companies in the industry (latest financial year, logarithmic scale). Amber bar: where this company sits.

Compared with similar companies

size, age and company form
Rank among similar companies
GroupGross profitEquity
Companies with 50–199 employees4,467 companies in the comparison
No. 476of 4,412
Better than 89%
No. 1,472of 4,466
Better than 67%
Same industry and 50–199 employees30 companies in the comparison
No. 18of 30
Better than 41%
No. 21of 30
Better than 31%
Companies that are at least 30 years old10,276 companies in the comparison
No. 731of 10,152
Better than 93%
No. 2,358of 10,275
Better than 77%
All companies of type A/S18,025 companies in the comparison
No. 1,333of 17,786
Better than 93%
No. 4,211of 18,024
Better than 77%

The rank is calculated among companies in the database with a figure for the latest financial year, and is shown only for groups of at least ten companies.

Compare with the industry

Wholesale of pharmaceutical goods and nursing supplies
Gross profit
  1. Glaxosmithkline Pharma A/SDKK 118.8m
  2. Ambu A/SDKK 3.6bn
  3. Stada Nordic ApSDKK 687m
Net profit
  1. Glaxosmithkline Pharma A/SDKK 13.1m
  2. Ambu A/SDKK 609m
  3. Stada Nordic ApSDKK 54.6m
Equity
  1. Glaxosmithkline Pharma A/SDKK 39m
  2. Ambu A/SDKK 6bn
  3. Stada Nordic ApSDKK 346.3m
Employees
  1. Glaxosmithkline Pharma A/S82
  2. Ambu A/S619
  3. Stada Nordic ApS51

Latest financial year per company. Choose up to three companies from the largest in the industry.

Owners and group

from the Public Ownership Register
Owners
  • Setfirst Limited100%
Glaxosmithkline Pharma A/S

Management

5 active registrations

Executive management

Executive management at Glaxosmithkline Pharma A/S
NameRoleAppointed
Diederik Maarten EijsvogelDirector26/08/2025

Board of directors

Board of directors at Glaxosmithkline Pharma A/S
NameRoleAppointed
Helle Ann HellbergBoard member01/05/2023
Luciano Alves de AndradeChair of the board18/06/2025
Diederik Maarten EijsvogelBoard member26/08/2025
Alastair William JonesBoard member18/06/2026
Former management (43)
Former management at Glaxosmithkline Pharma A/S
NameRoleAppointedResigned
Helge HasselBoard member11/12/196801/05/2001
Carl Christian Juhlsgaard JepsenBoard member11/12/196811/05/2000
Carl Christian Juhlsgaard JepsenDirector11/12/196811/05/2000
Angus RobertsonChair of the board11/12/196829/04/1996
Simon Cresey DavidsonChair of the board11/12/196818/03/1998
Siero Keimpe RoosjenChair of the board18/03/199818/01/2001
Frederik Jan van SnippenbergBoard member13/07/200018/01/2001
Frederik Jan van SnippenbergDirector13/07/200018/01/2001
Michael John CrowBoard member18/01/200115/01/2004
Michael John CrowDirector18/01/200115/01/2004
Douglas Malcolm HurtChair of the board18/01/200101/08/2003
Hans HedegaardBoard member01/05/200102/12/2010
Geradus Wilhelmus Maria van OdijkChair of the board01/08/200312/09/2005
Simon Anthony JoseBoard member15/01/200413/04/2007
Simon Anthony JoseCEO15/01/200401/05/2007
David Simon RedfernChair of the board12/09/200506/05/2008
Julie Maree EdwardsBoard member13/04/200719/04/2010
Julie Maree EdwardsCEO01/05/200719/04/2010
Frederik Jan van SnippenbergChair of the board06/05/200806/06/2012
Michael Francis ConnellBoard member19/04/201027/04/2012
Michael Francis ConnellCEO19/04/201027/04/2012
Ole Jensen-DahmBoard member02/12/201030/09/2020
Birgit Yvonne ReimannCEO27/04/201211/10/2013
Georgios KatzourakisChair of the board06/06/201211/10/2013
Judith Lynne StewartBoard member11/10/201302/12/2015
Judith Lynne StewartCEO11/10/201302/12/2015
Birgit Yvonne ReimannChair of the board11/10/201326/05/2015
Daniël GijbelsChair of the board26/05/201503/04/2017
Josephine Yang ComiskeyBoard member02/12/201502/04/2017
Josephine Yang ComiskeyCEO02/12/201503/04/2017
Josephine Yang ComiskeyChair of the board03/04/201715/06/2018
Saskia FonteinBoard member03/04/201730/10/2018
Saskia FonteinCEO03/04/201730/10/2018
Neale Andrew BelsonChair of the board15/06/201801/07/2020
David Mattheus Fredericus RademakersBoard member30/10/201801/05/2023
David Mattheus Fredericus RademakersCEO30/10/201801/05/2023
Anne Margaret BelcherChair of the board01/07/202001/01/2022
Tetiana LuczkiwBoard member30/09/202001/11/2023
Patrick Gerard ConnorChair of the board01/01/202218/06/2025
Hemal Depan MaldeBoard member01/05/202315/01/2025
Dominika M Wiktor-BrownBoard member01/05/202326/08/2025
Dominika M Wiktor-BrownDirector01/05/202326/08/2025
Joshua Rhys WilliamsBoard member15/01/202518/06/2026

Signing rule: Selskabet tegnes af en direktør i forening med et bestyrelsesmedlem, af to medlemmer af bestyrelsen i forening eller af den samlede bestyrelse.

Address and production units

1 active production units

Delta Park 37
2665 Vallensbæk Strand

Vallensbæk Municipality · Postcode 2665

Other companies at the address (6)

Production units
Production unitAddressEmployeesP number
GLAXOSMITHKLINE PHARMA A/SDelta Park 37, 2665 Vallensbæk Strand821003021729

Purpose

Selskabets formål er at drive handel

The purpose is quoted from the register in Danish.

Changes year by year

107 registered events
20263 changesaccounts 1 · management 2
  • Annual report for 2025 published
  • Alastair William Jones appointed board member
  • Joshua Rhys Williams stepped down as board member
202511 changesmanagement 8 · accounts 1 · address 2
  • Diederik Maarten Eijsvogel appointed director
  • Diederik Maarten Eijsvogel appointed board member
  • Dominika M Wiktor-Brown stepped down as director
  • Dominika M Wiktor-Brown stepped down as board member
  • Annual report for 2024 published
  • Luciano Alves de Andrade appointed chair of the board
  • Patrick Gerard Connor stepped down as chair of the board
  • Moved to Delta Park 37, 2665 Vallensbæk Strand
  • Joshua Rhys Williams appointed board member
  • Hemal Depan Malde stepped down as board member
  • Moved to Delta Park 37, 2665 Vallensbæk Strand
20241 changeaccounts 1
  • Annual report for 2023 published
20238 changesmanagement 7 · accounts 1
  • Tetiana Luczkiw stepped down as board member
  • Annual report for 2022 published
  • Hemal Depan Malde appointed board member
  • Helle Ann Hellberg appointed board member
  • Dominika M Wiktor-Brown appointed director
  • Dominika M Wiktor-Brown appointed board member
  • David Mattheus Fredericus Rademakers stepped down as board member
  • David Mattheus Fredericus Rademakers stepped down as ceo
20223 changesaccounts 1 · management 2
  • Annual report for 2021 published
  • Patrick Gerard Connor appointed chair of the board
  • Anne Margaret Belcher stepped down as chair of the board
20212 changesaccounts 1 · address 1
  • Annual report for 2020 published
  • Moved to Delta Park 37, 2665 Vallensbæk Strand
20204 changesmanagement 4
  • Tetiana Luczkiw appointed board member
  • Ole Jensen-Dahm stepped down as board member
  • Anne Margaret Belcher appointed chair of the board
  • Neale Andrew Belson stepped down as chair of the board
20186 changesmanagement 6
  • David Mattheus Fredericus Rademakers appointed board member
  • David Mattheus Fredericus Rademakers appointed ceo
  • Saskia Fontein stepped down as board member
  • Saskia Fontein stepped down as ceo
  • Neale Andrew Belson appointed chair of the board
  • Josephine Yang Comiskey stepped down as chair of the board
20176 changesmanagement 6
  • Saskia Fontein appointed board member
  • Saskia Fontein appointed ceo
  • Josephine Yang Comiskey appointed chair of the board
  • Josephine Yang Comiskey stepped down as ceo
  • Daniël Gijbels stepped down as chair of the board
  • Josephine Yang Comiskey stepped down as board member
20157 changesmanagement 6 · ownership 1
  • Josephine Yang Comiskey appointed board member
  • Josephine Yang Comiskey appointed ceo
  • Judith Lynne Stewart stepped down as board member
  • Judith Lynne Stewart stepped down as ceo
  • Daniël Gijbels appointed chair of the board
  • Birgit Yvonne Reimann stepped down as chair of the board
  • Setfirst Limited registered as owner (100%)
20135 changesmanagement 5
  • Judith Lynne Stewart appointed board member
  • Judith Lynne Stewart appointed ceo
  • Birgit Yvonne Reimann appointed chair of the board
  • Georgios Katzourakis stepped down as chair of the board
  • Birgit Yvonne Reimann stepped down as ceo
20125 changesmanagement 5
  • Georgios Katzourakis appointed chair of the board
  • Frederik Jan van Snippenberg stepped down as chair of the board
  • Birgit Yvonne Reimann appointed ceo
  • Michael Francis Connell stepped down as ceo
  • Michael Francis Connell stepped down as board member
20106 changesmanagement 6
  • Ole Jensen-Dahm appointed board member
  • Hans Hedegaard stepped down as board member
  • Michael Francis Connell appointed ceo
  • Michael Francis Connell appointed board member
  • Julie Maree Edwards stepped down as ceo
  • Julie Maree Edwards stepped down as board member
20082 changesmanagement 2
  • Frederik Jan van Snippenberg appointed chair of the board
  • David Simon Redfern stepped down as chair of the board
20074 changesmanagement 4
  • Julie Maree Edwards appointed ceo
  • Simon Anthony Jose stepped down as ceo
  • Julie Maree Edwards appointed board member
  • Simon Anthony Jose stepped down as board member
20052 changesmanagement 2
  • David Simon Redfern appointed chair of the board
  • Geradus Wilhelmus Maria van Odijk stepped down as chair of the board
20044 changesmanagement 4
  • Simon Anthony Jose appointed ceo
  • Simon Anthony Jose appointed board member
  • Michael John Crow stepped down as director
  • Michael John Crow stepped down as board member
20032 changesmanagement 2
  • Geradus Wilhelmus Maria van Odijk appointed chair of the board
  • Douglas Malcolm Hurt stepped down as chair of the board
20018 changesmanagement 8
  • Hans Hedegaard appointed board member
  • Helge Hassel stepped down as board member
  • Douglas Malcolm Hurt appointed chair of the board
  • Michael John Crow appointed director
  • Michael John Crow appointed board member
  • Frederik Jan van Snippenberg stepped down as board member
  • Frederik Jan van Snippenberg stepped down as director
  • Siero Keimpe Roosjen stepped down as chair of the board
20004 changesmanagement 4
  • Frederik Jan van Snippenberg appointed board member
  • Frederik Jan van Snippenberg appointed director
  • Carl Christian Juhlsgaard Jepsen stepped down as director
  • Carl Christian Juhlsgaard Jepsen stepped down as board member
19982 changesmanagement 2
  • Siero Keimpe Roosjen appointed chair of the board
  • Simon Cresey Davidson stepped down as chair of the board
19961 changemanagement 1
  • Angus Robertson stepped down as chair of the board
19954 changesname 2 · capital 1 · merger 1
  • Name changed from GLAXO DANMARK A/S to GLAXOSMITHKLINE PHARMA A/S
  • Share capital changed from 450,000 DKK to 10,000,000 DKK
  • Name changed from GLAXO WELLCOME A/S to GLAXO DANMARK A/S
  • Merger registered in CVR
19891 changename 1
  • Name changed from GLAXO LÆGEMIDLER A/S to GLAXO WELLCOME A/S
19686 changesfounded 1 · management 5
  • Registered as GLAXO LÆGEMIDLER A/S
  • Carl Christian Juhlsgaard Jepsen appointed director
  • Simon Cresey Davidson appointed chair of the board
  • Angus Robertson appointed chair of the board
  • Carl Christian Juhlsgaard Jepsen appointed board member
  • Helge Hassel appointed board member

Related companies

Same industry in Vallensbæk

See all →

Same people in management

Largest in the industry

See all →

Source and updates

The information comes from the Danish Central Business Register (Danish Business Authority) and from annual reports filed with the Danish Business Authority. Last synchronised 24/10/2026.

View in CVRReport a correction